Literature DB >> 15938188

Novel steroids from the seeds of Centratherum anthelminticum.

B K Mehta1, Darshana Mehta, Manjul Verma.   

Abstract

Two novel and two known steroids were isolated respectively from benzene: acetone and ethanolic extracts of the seeds of C. anthelminticum and, identified as (24alpha/R)-Stigmasta-7-en-3-one (1), (24alpha/R)-Stigmasta-7, 9(11)-dien-3-one (2), (24alpha/S)-Stigmasta-5, 22-dien-3beta-ol (3) and (24alpha/S)-Stigmasta-7, 22-dien-3beta-ol (4). The structures were assigned on the basis of their IR, 1H NMR, 13C NMR (DEPT), 2D NMR (1H-1H COSY and 1H-13C COSY), mass spectra, chemical analyses and on comparison with literature values. The novel steroids (1) and (2) were also tested against several human pathogenic bacteria and fungi.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15938188     DOI: 10.1080/14786410512331330729

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  4 in total

1.  Evaluation of Analgesic and Antipyretic Activities of Centratherum anthelminticum (L) Kuntze Seed.

Authors:  A Purnima; B C Koti; V P Tikare; A H M Viswanathaswamy; A H M Thippeswamy; P Dabadi
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

2.  Antioxidant potential of bitter cumin (Centratherum anthelminticum (L.) Kuntze) seeds in in vitro models.

Authors:  V Ani; Kamatham A Naidu
Journal:  BMC Complement Altern Med       Date:  2011-05-20       Impact factor: 3.659

3.  Evaluation of Antiinflammatory Activity of Centratherum anthelminticum (L) Kuntze Seed.

Authors:  Purnima Ashok; B C Koti; A H M Thippeswamy; V P Tikare; P Dabadi; A H M Viswanathaswamy
Journal:  Indian J Pharm Sci       Date:  2010-11       Impact factor: 0.975

4.  Chloroform Fraction of Centratherum anthelminticum (L.) Seed Inhibits Tumor Necrosis Factor Alpha and Exhibits Pleotropic Bioactivities: Inhibitory Role in Human Tumor Cells.

Authors:  Aditya Arya; Mouna Achoui; Shiau-Chuen Cheah; Siddig Ibrahim Abdelwahab; Putri Narrima; Syam Mohan; Mohd Rais Mustafa; Mustafa Ali Mohd
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-28       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.